In the context of breast cancer, NDRG1 appears to be multifaceted, as it has been proposed to act as a promoter of tumor growth and brain metastasis in some cases of estrogen receptor–negative (ER-negative), aggressive breast cancers (63, 64). This evidence concerns the gene NDRG1 and breast carcinoma.